CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer
Jiewei Chen,1,2,* Qingmei He,2,* Jun Liu,1,2,* Yongbo Xiao,1 Canhua Xiao,3 Keming Chen,1 Dan Xie,1,2 Xinke Zhang1,2 1Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of China; 2Sun Yat-sen University Cancer Center, State Key Laboratory of...
Main Authors: | Chen J, He Q, Liu J, Xiao Y, Xiao C, Chen K, Xie D, Zhang X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/cd8-tumor-infiltrating-lymphocytes-as-a-novel-prognostic-biomarker-in--peer-reviewed-article-CMAR |
Similar Items
-
The Prognostic Significance Of JMJD3 In Primary Sarcomatoid Carcinoma Of The Lung, A Rare Subtype Of Lung Cancer
by: Li S, et al.
Published: (2019-11-01) -
Overexpression of p53R2 is associated with poor prognosis in lung sarcomatoid carcinoma
by: Jiewei Chen, et al.
Published: (2017-12-01) -
An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)
by: Haoyue Guo, et al.
Published: (2021-01-01) -
Decreased CD8+ Lymphocytic Infiltration in Multifocal and Multicentric Glioblastomas
by: Run Wang, et al.
Published: (2021-09-01) -
Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases
by: Wenjuan Yu, et al.
Published: (2017-04-01)